The role of Convalescent Plasma in modulating the inflammatory response in COVID-19 patients
DOI:
https://doi.org/10.33448/rsd-v13i12.47794Keywords:
Antibodies; Immunity; Pandemic.Abstract
Introduction: The COVID-19 pandemic has had a devastating impact on global public health, causing over 6.9 million deaths. Many therapeutic strategies were used in an attempt to find a cure and prevent complications from this infection. Among these was convalescent plasma therapy, which involves the transfusion of plasma from individuals who have recovered from the infection, containing specific antibodies against the pathogen. Objective: To evaluate the effectiveness of convalescent plasma therapy in improving the clinical condition of hospitalized COVID-19 patients and its relationship with plasma levels of anti-SARS-CoV-2 antibodies. Methodology: A bibliographic search was conducted on the PubMed and Virtual Health Library platforms, and through inclusion and exclusion criteria, 20 articles were selected to support this systematic literature review. Results: This study showed that among the 20 articles included, 11 reported positive results regarding the use of convalescent plasma in modulating the inflammatory response of patients infected with the SARS-CoV-2 virus. Although this therapy did not present adverse effects, it did not affect the incidence of long-term symptoms, did not reduce mortality, and led to an increase in anti-SARS-CoV-2 antibody levels that was insufficient to alter the course of the disease in question. Conclusion: Although the administration of convalescent plasma is free of adverse effects, its effectiveness remains uncertain, and its use as a monotherapy is not recommended. Therefore, more research is needed to establish its applicability and true effectiveness.
References
Abdullah, M. R., Alam Faizli, A., Adzaludin, N. S., Abu Amin, N., Misnan, N. A., & Low, L. L. (2023). Convalescent plasma transfusion in severe COVID-19 patients: Clinical and laboratory outcomes. The Malaysian Journal of Pathology, 45(1), 87–95.
Bégin, P., Callum, J., Jamula, E., Cook, R., Heddle, N. M., Tinmouth, A., Zeller, M. P., Beaudoin-Bussières, G., Amorim, L., Bazin, R., Loftsgard, K. C., Carl, R., Chassé, M., Cushing, M. M., Daneman, N., Devine, D. V., Dumaresq, J., Fergusson, D. A., Gabe, C., Glesby, M. J., … Arnold, D. M. (2021). Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial. Nature Medicine, 27(11), 2012–2024. https://doi.org/10.1038/s41591-021-01488-2
Bihariesingh-Sanchit, R., Bansie, R., Ramdhani, N., Mangroo, R., Bustamente, D., Diaz, E., Fung A Foek, C., Thakoer, I., Vreden, S., Choudhry, Z., van 't Wout, A. B., Diavatopoulos, D. A., & Nierich, A. P. (2023). Reduced mortality among COVID-19 ICU patients after treatment with HemoClear convalescent plasma in Suriname. mBio, 14(2), e0337922. https://doi.org/10.1128/mbio.03379-22
Budhiraja, S., Dewan, A., Aggarwal, R., Singh, O., Juneja, D., Pathak, S., Singh, Y. P., Gupta, A., Rai, R., Indrayan, A., Jha, V., & Naithani, R. (2021). Effectiveness of convalescent plasma in Indian patients with COVID-19. Blood Cells, Molecules, and Diseases, 88, 102548. https://doi.org/10.1016/j.bcmd.2021.102548
Costa, T. P., Aoki, M., Ribeiro, C. M., Socca, E., Itinose, L., Basso, R., & Blanes, L. (2024). Efficacy of convalescent plasma in hospitalized COVID-19 patients: findings from a controlled trial. Brazilian Journal of Medical and Biological Research, 57, e13627. https://doi.org/10.1590/1414-431X2024e13627
Desmarets, M., Hoffmann, S., Vauchy, C., Rijnders, B. J. A., Toussirot, E., Durrbach, A., Körper, S., Schrezenmeier, E., van der Schoot, C. E., Harvala, H., Brunotte, G., Appl, T., Seifried, E., Tiberghien, P., Bradshaw, D., Roberts, D. J., Estcourt, L. J., & Schrezenmeier, H. (2023). Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 (COVIC-19): protocol for a randomised, open-label trial. BMJ Open, 13(4), e071277. https://doi.org/10.1136/bmjopen-2022-071277
Filippatos, C., Ntanasis-Stathopoulos, I., Sekeri, K., Ntanasis-Stathopoulos, A., Gavriatopoulou, M., Psaltopoulou, T., Dounias, G., Sergentanis, T. N., & Terpos, E. (2023). Convalescent plasma therapy for COVID-19: A systematic review and meta-analysis on randomized controlled trials. Viruses, 15(3), 765. https://doi.org/10.3390/v15030765
Franchini, M., Cruciani, M., Mengoli, C., Casadevall, A., Glingani, C., Joyner, M. J., Pirofski, L. A., Senefeld, J. W., Shoham, S., Sullivan, D. J., Zani, M., & Focosi, D. (2024). Convalescent plasma and predictors of mortality among hospitalized patients with COVID-19: a systematic review and meta-analysis. Clinical Microbiology and Infection, S1198-743X(24)00353-7. https://doi.org/10.1016/j.cmi.2024.07.020
Gomes, I. S., & Caminha, I. D. O. (2013). Guia para estudos de revisão sistemática: uma opção metodológica para as ciências do movimento humano. Movimento (ESEFID/UFRGS), 20(1), 395. https://doi.org/10.22456/1982-8918.41542
Ghadami, L., Hasibi, M., Asadollahi-Amin, A., Hasanjarani, B., Farahmand, M., & Abdollahi, H. (2022). Convalescent plasma therapy in patients with severe COVID-19, A single-arm, retrospective study. Microbial Pathogenesis, 165, 105482. https://doi.org/10.1016/j.micpath.2022.105482
Habtehyimer, F., Zhu, X., Redd, A. D., Gebo, K. A., Abraham, A. G., Patel, E. U., Laeyendecker, O., Gniadek, T. J., Fernandez, R. E., Baker, O. R., Ram, M., Cachay, E. R., Currier, J. S., Fukuta, Y., Gerber, J. M., Heath, S. L., Meisenberg, B., Huaman, M. A., Levine, A. C., Shenoy, A., … Sullivan, D. J. (2024). COVID-19 convalescent plasma therapy decreases inflammatory cytokines: a randomized controlled trial. Microbiology Spectrum, 12(1), e0328623. https://doi.org/10.1128/spectrum.03286-23
Heidari, M., Ramin Yaghobi, Mohsen Moghadami, Zand, F., Fallahi, M. J., Pourfathollah, A. A., Golnoush Zarnegar, Salah, A., Saeedeh Soleimanian, Golshan, M., Jangjoo, A., & Karimi, M. H. (2024). Assessment of immunological factors in COVID-19 patients treated by convalescent plasma. Cellular and Molecular Biology, 70(9), 1–9. https://doi.org/10.14715/cmb/2024.70.9.1
Hueso, T., Pouderoux, C., Péré, H., Beaumont, A.-L., Raillon, L.-A., Ader, F., Chatenoud, L., Eshagh, D., Szwebel, T.-A., Martinot, M., Camou, F., Crickx, E., Michel, M., Mahevas, M., Boutboul, D., Azoulay, E., Joseph, A., Hermine, O., Rouzaud, C., & Faguer, S. (2020). Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19. Blood, 136(20), 2290–2295. https://doi.org/10.1182/blood.2020008423
Iannizzi, C., Chai, K. L., Piechotta, V., Valk, S. J., Kimber, C., Monsef, I., Wood, E. M., Lamikanra, A. A., Roberts, D. J., McQuilten, Z., So-Osman, C., Jindal, A., Cryns, N., Estcourt, L. J., Kreuzberger, N., & Skoetz, N. (2023). Convalescent plasma for people with COVID-19: a living systematic review. The Cochrane Database of Systematic Reviews, 2(2), CD013600. https://doi.org/10.1002/14651858.CD013600.pub5
Janoff, E. N., Brown, S. T., Belitskaya-Levy, I., Curtis, J. L., Bonomo, R. A., Miller, E. K., Goldberg, A. M., Zehm, L., Wills, A., Hutchinson, C., Dumont, L. J., Gleason, T., Shih, M. C., & ADD Caitlin MS in CCTC website. (2023). Design of VA Coronavirus Research and Efficacy Studies-1 (VA CURES-1): A double-blind, randomized placebo-controlled trial of COVID-19 convalescent plasma in hospitalized patients with early respiratory compromise. Contemporary Clinical Trials Communications, 35, 101190. https://doi.org/10.1016/j.conctc.2023.101190
Kandula, U. R., Tuji, T. S., Gudeta, D. B., Bulbula, K. L., Mohammad, A. A., Wari, K. D., & Abbas, A. (2023). Effectiveness of COVID-19 Convalescent Plasma (CCP) During the Pandemic Era: A Literature Review. Journal of Blood Medicine, 14, 159–187. https://doi.org/10.2147/JBM.S397722
Körper, S., Seifried, E., & Schrezenmeier, H. (2023). Zum Stellenwert von Rekonvaleszentenplasma bei der Therapie von COVID-19 [Value of convalescent plasma in the therapy of COVID-19]. Deutsche Medizinische Wochenschrift, 148(7), 423–426. https://doi.org/10.1055/a-2013-8775
Kumar, N. R., Karanam, V. C., Kumar, S., & Kumar, S. D. (2023). Convalescent Plasma Therapy in Late-State, Severe COVID-19 Infection. Southern Medical Journal, 116(5), 427–433. https://doi.org/10.14423/SMJ.0000000000001546
McDyer, J. F., Azimpouran, M., Durkalski-Mauldin, V. L., Clevenger, R. G., Yeatts, S. D., Deng, X., Barsan, W., Silbergleit, R., El Kassar, N., Popescu, I., Dimitrov, D., Li, W., Lyons, E. J., Lieber, S. C., Stone.
Moravec, J., Müller, M., Turek, P., Moravec, M., Nejtek, T., & Zazula, R. (2023). Efeito da terapia com plasma convalescente na mortalidade e carga viral em pacientes gravemente doentes com COVID-19. Prague Medical Report, 124(3), 230–241. https://doi.org/10.14712/23362936.2023.18
Pereira, A. S., Shitsuka, D. M., Parreira, F. J., & Shitsuka, R. (2018). Metodologia da pesquisa científica. In repositorio.ufsm.br. Brasil.
Sofie, L., Macpherson, M. E., Skeie, L. G., Marte Hvalryg, Abid Hussain Llohn, Tine Torsvik Steinsvåg, Fenstad, M. H., Anders Tveita, Kristoffersen, E. K., Tatjana Sundic, Fridtjof Lund-Johansen, Vaage, J. T., Øystein Flesland, Dyrhol-Riise, A. M., Holter, J. C., Tor Audun Hervig, & Børre Fevang. (2023). COVID-19 patients treated with convalescent plasma. Tidsskrift for Den Norske Legeforening, 143(11). https://doi.org/10.4045/tidsskr.22.0577
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Mark Aragão dos Santos Silva; Julia Menezes Vignoli ; Juliana Silveira Sola ; Maria Antonia Louro; Maria Luiza Scandiuzzi Lopes; Maria Eduarda Lutterbach Guimarães Monnerat; Cristina Maria Monteiro Dantas
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
